MET offers enhanced tissue penetration of effective drug ingredients that were once a challenge to formulate
MET is a unique nanotechnology, developed by Nanomerics, Ltd., that allows a hydrophobic drug to be encapsulated and delivered directly to targeted tissues without the use of surfactants and oils. MET can enhance the delivery of effective insoluble drugs at higher concentrations to relevant tissues without systemic exposure.
How it works
A novel way to deliver effective treatments
IACTA is bringing this cutting-edge technology to the eye care industry
With patent licensing from Nanomerics, Ltd., we are combining MET with effective ocular treatments to enhance the drug delivery of eye care products.
Oil free: MET does not require the use of oils and surfactants which can irritate the eye
High drug loading capacity: The MET nanoparticles can be loaded with high efficacy of the active drug for maximize product delivery to ocular tissues
Sustained drug release properties: MET formulations allow for effective dosing regimen
Ocular bio adhesive properties: MET allows topical ocular delivery of an insoluble drug across biological barriers, such as the cornea, without systemic exposure
Connect with us